Long-circulating polymeric nanovectors for tumor-selective gene delivery (Q36314788)

13 August 2017

1 reference

title

Long-circulating polymeric nanovectors for tumor-selective gene delivery (English)

1 reference

13 August 2017

Sushma Kommareddy

1

1 reference

PubMed ID

16292881

13 August 2017

Sandip B Tiwari

series ordinal

2

1 reference

PubMed ID

16292881

13 August 2017

Mansoor M Amiji

series ordinal

3

1 reference

13 August 2017

1 December 2005

1 reference

Technology in Cancer Research and Treatment

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

6

1 reference

13 August 2017

615-625

1 reference

Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.

13 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Cytochrome P450-based cancer gene therapy: recent advances and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Pharmacological aspects of targeting cancer gene therapy to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

DNA-based therapeutics and DNA delivery systems: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Virus treatment questioned after gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Gene therapy. Second child in French trial is found to have leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

In vivo characteristics of cationic liposomes as delivery vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

An overview of current delivery systems in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Characteristics and biodistribution of cationic liposomes and their DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

In vivo targeted gene transfer into liver cells mediated by a novel galactosyl-D-lysine/D-serine copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Polymer-coated long-circulating microparticulate pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Dextrans for targeted and sustained delivery of therapeutic and imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Pegylation: engineering improved biopharmaceuticals for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Chemistry for peptide and protein PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Novel effects with polyethylene glycol modified pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Clinical uses of pegylated pharmaceuticals in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Pegylation: a novel process for modifying pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Polyethylene glycol modification: relevance of improved methodology to tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Synthesis, hybridization properties, nuclease stability, and cellular uptake of the oligonucleotide--amino-beta-cyclodextrins and adamantane conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

DNA complexing with polyamidoamine dendrimers: implications for transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Long circulation of intravenously administered plasmid DNA delivered with dendritic poly(L-lysine) in the blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Tumor targeting with surface-shielded ligand--polycation DNA complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Influence of polymer architecture on the structure of complexes formed by PEG-tertiary amine methacrylate copolymers and phosphorothioate oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

Structure–activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460500400605

10.1177/153303460500400605

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16292881